Ariad Pharmaceuticals (ARIA) Misses Q1 EPS By 4c; Comments on Outlook
Tweet Send to a Friend
Ariad Pharmaceuticals (Nasdaq: ARIA) reports a Q1 loss of $0.21, 4 cents worse than the analyst estimate of ($0.17) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
